Real-World Effectiveness of Mepolizumab in Patients With Chronic Rhinosinusitis With Nasal Polyps: Findings From the European CRS Outcome Registry (CHRINOSOR).

Alobid I, Seys SF, de Kinderen J, Hox V, Cavaliere C, Andrianakis A, Schneider S, Wagenmann M, Bruch M, Izquierdo-Domínguez A, Gonzalez-Compta X, Muñoz LP, Van Gerven L, Hellings PW, Mortuaire G, Burian M, Golet-Fors M, Moyaert M, Tomazic PV, Bettio G, de Vincentiis M, Diamant Z, Eckl-Dorna J, Mariën G, Masieri S, Morgenstern C, Scheckenbach K, Tu A, Rodriguez van Strahlen C, Bachert C, CHRINOSOR consortium

Open source

DOI
10.1002/clt2.70153
Published
2026 Feb
Container
Clinical and translational allergy
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/clt2.70153,
  title = {Real-World Effectiveness of Mepolizumab in Patients With Chronic Rhinosinusitis With Nasal Polyps: Findings From the European CRS Outcome Registry (CHRINOSOR).},
  author = {Alobid I and Seys SF and de Kinderen J and Hox V and Cavaliere C and Andrianakis A and Schneider S and Wagenmann M and Bruch M and Izquierdo-Domínguez A and Gonzalez-Compta X and Muñoz LP and Van Gerven L and Hellings PW and Mortuaire G and Burian M and Golet-Fors M and Moyaert M and Tomazic PV and Bettio G and de Vincentiis M and Diamant Z and Eckl-Dorna J and Mariën G and Masieri S and Morgenstern C and Scheckenbach K and Tu A and Rodriguez van Strahlen C and Bachert C and CHRINOSOR consortium},
  year = {2026},
  journal = {Clinical and translational allergy},
  doi = {10.1002/clt2.70153},
  url = {https://doi.org/10.1002/clt2.70153}
}

RIS

TY  - JOUR
TI  - Real-World Effectiveness of Mepolizumab in Patients With Chronic Rhinosinusitis With Nasal Polyps: Findings From the European CRS Outcome Registry (CHRINOSOR).
AU  - Alobid I
AU  - Seys SF
AU  - de Kinderen J
AU  - Hox V
AU  - Cavaliere C
AU  - Andrianakis A
AU  - Schneider S
AU  - Wagenmann M
AU  - Bruch M
AU  - Izquierdo-Domínguez A
AU  - Gonzalez-Compta X
AU  - Muñoz LP
AU  - Van Gerven L
AU  - Hellings PW
AU  - Mortuaire G
AU  - Burian M
AU  - Golet-Fors M
AU  - Moyaert M
AU  - Tomazic PV
AU  - Bettio G
AU  - de Vincentiis M
AU  - Diamant Z
AU  - Eckl-Dorna J
AU  - Mariën G
AU  - Masieri S
AU  - Morgenstern C
AU  - Scheckenbach K
AU  - Tu A
AU  - Rodriguez van Strahlen C
AU  - Bachert C
AU  - CHRINOSOR consortium
PY  - 2026
JO  - Clinical and translational allergy
DO  - 10.1002/clt2.70153
UR  - https://doi.org/10.1002/clt2.70153
ER  - 

APA

I, A., SF, S., J, D. K., V, H., C, C., A, A., S, S., M, W., M, B., A, I., X, G., LP, M., L, V. G., PW, H., G, M., M, B., M, G., M, M., PV, T., G, B., M, D. V., Z, D., J, E., G, M., S, M., C, M., K, S., A, T., C, R. V. S., C, B., & consortium, C. (2026). Real-World Effectiveness of Mepolizumab in Patients With Chronic Rhinosinusitis With Nasal Polyps: Findings From the European CRS Outcome Registry (CHRINOSOR).. Clinical and translational allergy. https://doi.org/10.1002/clt2.70153

Source records